Search results
Added:
5 years ago
Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology
Questions:
1. Why did you conduct this analysis?
2. How was data collected and analysed?
3. What were your findings?
4. How…
View more
Added:
1 year ago
This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice.
In this third and final discussion of the series, Dr Mikhail Kosiborod(Saint Luke’s Mid America Heart Institute, US) and Dr Shelley Zieroth (St Boniface Hospital, Winnipeg, CA)discuss the adoption of patient reported outcomes in…
View more
Added:
5 years ago
Dr Federico M Asch (Washington Hospital Center, Washington DC, US) discusses echocardiographic outcomes from the COAPT trial - mitral regurgitation after MitraClip implantation in patients with HF and secondary mitral regurgitation.Filmed on-site at ACC 2019 by Radcliffe Cardiology.
Videographer: Josh Birch
Educational Lead: Liam O'Neill, Chief Operating Officer
View more
Added:
3 years ago
Added:
1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular…
View more
Added:
3 years ago
This roundtable eventincludes four leading heart failure specialists discussing recentdata related to SGLT2 inhibitors in reducing CV risk, HF hospitalisations andmortality and morbidity in HFrEF irrespective of T2DM. The panel also look at ongoing studies including those for HFpEF and CKD outcomes.
View more
Added:
5 years ago
Dr Aaisha Opel discusses 'Empowering Teams to Improve Atrial Fibrillaiton Ablation Efficiency and Outcomes' at EHRA 2018.
View more
Added:
1 year ago
Iron deficiency is common in heart failure, particularly in hospitalised patients and may exacerbate symptoms and increase the risk of hospitalisation and premature mortality. Although previous studies have shown that intravenous iron provides improvement in exercise capacity and reduces hospitalisation in patients with HF and iron deficiency, longer term efficacy and safety data has been lacking…
View more
Added:
2 years ago
Added:
5 years ago
Dr Aaisha Opel discusses 'Empowering Teams to Improve Atrial Fibrillaiton Ablation Efficiency and Outcomes' at EHRA 2018.
Filmed by Radcliffe Cardiology on site EHRA 2018.
View more
